Wealth Alliance Advisory Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
B
MSV
CNB
AP
II
CA
SC
AF
Wealth Alliance Advisory Group's GILD Position: Q3 2026 in Review
Wealth Alliance Advisory Group increased its Gilead Sciences (GILD) stake by 0.38% in Q3 2026, buying an estimated $1.26K and bringing the position to 2,354 shares worth $351K. The position accounts for 0.05% of the portfolio, ranked #155.
Wealth Alliance Advisory Group first reported a position in GILD in Q1 2018 and has held it in 20 quarters since. 234 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Wealth Alliance Advisory Group held 2,354 shares of Gilead Sciences worth $351K as of Q3 2026.
- Wealth Alliance Advisory Group bought 9 Gilead Sciences shares in Q3 2026, an estimated $1.26K.
- Gilead Sciences made up 0.05% of Wealth Alliance Advisory Group's portfolio in Q3 2026, its #155 holding.
- Wealth Alliance Advisory Group first reported a position in Gilead Sciences in Q1 2018 and has held it in 20 quarters since.
- 234 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Wealth Alliance Advisory Group's 13F filing for Q3 2026, filed 14 Oct 2026.